Study at a glance
How does the body control vitamin D removal?
Proteins called enzymes break down forms of vitamin D. Hormones and mineral levels help control both the production and removal of active vitamin D, so the body controls how it is removed.
Does vitamin D breakdown have the same effect in every organ?
No. In the mouse experiments discussed here, removing a breakdown enzyme from the kidneys raised vitamin D levels in blood. Removing it from the intestine mainly increased local vitamin D activity without the same rise in blood levels.
Can local vitamin D activity affect the rest of the body?
Yes. Changes in the mouse intestine altered hormones involved in calcium balance, even without a matching change in active vitamin D in the blood. Some effects differed between experimental conditions.
Do these findings establish a treatment for people?
No. The results in different tissues came from mice. They help explain vitamin D control but do not establish the safety or benefits of blocking this enzyme in humans.
Read the full article below ↓Vitamin D clearance is a regulated biological process rather than a fixed disposal rate. The amount of active vitamin D available at any moment reflects the balance between formation, degradation, endocrine feedback and tissue location. Three evidence streams help define that system. Jones and colleagues describe CYP24A1 catabolic chemistry. Young and colleagues examine renal regulation of CYP27B1 and CYP24A1. Fuchs and colleagues test whether CYP24A1 has the same physiological effect in kidney and intestine.
The combined model extends the core physiology described in Vitamin D Clearance and Degradation.
CYP24A1 provides a major pathway for vitamin D catabolism
Jones and colleagues describe CYP24A1 as a central enzyme in vitamin D catabolism. It can metabolise both 25(OH)D and 1,25(OH)₂D through multistep C24 and C23 oxidation pathways. Which route dominates depends partly on species and enzyme structure.
The physiological importance of the enzyme is illustrated by Cyp24a1 null mice. The reviewed evidence includes an increase in the plasma half life of 1,25(OH)₂D from approximately 6 hours to approximately 60 hours when CYP24A1 is absent.
The detailed evidence is presented in Cellular Degradation and Feedback Regulation of Vitamin D: Full Evidence Review.
CYP24A1 is not the only pathway involved in vitamin D catabolism. CYP3A4 can contribute in selected tissues and exposure settings. The first oxidative step should therefore not be treated as an instantaneous or universal biological off switch.
The relationship between activation and degradation is set out in Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1).
PTH coordinates increased activation with reduced catabolic pressure
Young and colleagues describe how the renal proximal tubule coordinates CYP27B1 and CYP24A1. PTH stimulates CYP27B1 and also acts on the catabolic side of the system. The review reports that PTH can reduce CYP24A1 mRNA half life by approximately fourfold.
This gives PTH two complementary ways to favour calcitriol availability: greater formation through CYP27B1 and weaker persistence of the transcript supporting CYP24A1 mediated catabolism.
The renal evidence is developed in Pathophysiological Consequences of Altered Enzyme Activity: Full Evidence Review.
Calcitriol provides direct negative feedback on its own availability
Calcitriol feeds back through vitamin D receptor signalling. In the renal system it suppresses CYP27B1 while inducing CYP24A1. This reduces further calcitriol formation while increasing catabolic capacity.
Calcitriol also suppresses PTH transcription. The feedback network therefore operates at several levels rather than through one isolated enzyme reaction. This broader hormonal interaction is described in Vitamin D and Endocrine Crosstalk.
FGF23 moves renal vitamin D metabolism toward lower calcitriol availability
FGF23 acts in the opposite overall direction to PTH. It suppresses CYP27B1 and favours the catabolic side of the pathway. Young and colleagues report that FGF23 null mice had approximately threefold greater renal CYP27B1 promoter activity and about 63% lower renal Cyp24a1 mRNA than wild type animals.
The physiological direction is clearer than every molecular step. The complete route by which FGF23 promotes CYP24A1 is not fully resolved. The wider mineral feedback network is covered in Vitamin D and Phosphate Regulation.
Calcium, phosphate and calcitonin prevent the regulatory map becoming too simple
Calcitonin generally stimulates CYP27B1 in experimental systems, but its reported effect on CYP24A1 differs between models. In one animal context calcitonin reduced Cyp24a1 expression. In calcitonin receptor transfected HEK 293 cells it induced CYP24A1, and inhibition of PKA and PKC reduced that response by about 60%.
Phosphate depletion can increase renal CYP27B1 and calcitriol production by about threefold in cited experiments even when PTH is not the sole driver. Calcium can also oppose PTH stimulated CYP27B1 activity in experimental models. These findings show that mineral feedback is real while several sensing mechanisms remain incomplete.
The calcium side of this network is explained in Vitamin D Calcium Physiology.
The Fuchs experiment shows why tissue location changes the meaning of CYP24A1 activity
Fuchs and colleagues add a causal tissue experiment. They compared global, renal and intestinal deletion of Cyp24a1 after verifying tissue specificity and loss of enzyme function.
Renal deletion reproduced much of the global systemic vitamin D phenotype. Intestinal deletion instead increased local intestinal vitamin D receptor activity without producing the same rise in circulating vitamin D metabolites.
The difference can be interpreted within How Cellular Vitamin D Metabolism Differs Between Tissues.
Local intestinal signalling can alter calcium feedback without raising circulating calcitriol
Under standard conditions, global and renal deletion increased 1,25D and 25D, reduced 24,25D, suppressed PTH and raised FGF23. Intestinal deletion instead increased local vitamin D receptor responsive gene activity while leaving the systemic vitamin D profile largely unchanged.
The result demonstrates the distinction described in Vitamin D Metabolism at the Cellular Level: circulating concentration and local tissue activity are related but not identical properties.
During a diet containing 2.0% calcium, global and renal deletion produced or worsened hypercalcaemia. Intestinal deletion did not. Yet PTH was suppressed in the intestinal knockout despite unchanged serum calcium and circulating 1,25D. For a given serum calcium concentration, the urine calcium to creatinine ratio was 0.72 units higher than in controls, with a 95% confidence interval from 0.18 to 1.26 and P = 0.01.
This finding also connects with Vitamin D and Intracrine Activity, where local vitamin D action is considered separately from systemic endocrine concentration.
The chronic kidney disease model extends the tissue effect into endocrine feedback
In the adenine kidney disease model, intestinal Cyp24a1 deletion attenuated the increases in PTH and FGF23 without increasing serum calcium or phosphate and without reducing the severity of kidney injury.
This provides evidence that changing local intestinal vitamin D metabolism can influence systemic endocrine feedback without requiring a matching increase in circulating calcitriol.
The experiment remains mouse evidence. It does not establish a safe human CYP24A1 inhibitor, clinical efficacy, long term skeletal benefit or cardiovascular benefit.
FGF23 demonstrates why context must remain attached to the result
FGF23 did not move in one universal direction after intestinal CYP24A1 deletion. It increased modestly during the calcium challenge but was significantly lower during chronic kidney disease. PTH was reduced in both settings.
The mechanism of this divergence was unresolved. The evidence therefore does not justify converting one disease result into a general claim that intestinal CYP24A1 always drives FGF23 upward or downward.
The integrated model has chemical, endocrine and tissue levels
At the chemical level, CYP24A1 controls multistep oxidation of vitamin D metabolites, while other enzymes can contribute in selected contexts.
At the endocrine level, PTH, calcitriol and FGF23 coordinate formation and degradation in opposing directions, while calcium, phosphate and calcitonin add further regulation.
At the tissue level, renal CYP24A1 can strongly influence systemic exposure while intestinal CYP24A1 can regulate local signalling and downstream calcium and PTH physiology.
These levels should not be collapsed into one another. Enzyme chemistry cannot substitute for tissue physiology, renal regulation cannot predict every intestinal effect, and a tissue deletion experiment cannot map the entire endocrine system.
What the combined evidence establishes
The strongest overall conclusion is that vitamin D clearance is a feedback regulated and tissue organised process rather than a single passive elimination step.
CYP24A1 is a major catabolic control point. Renal CYP24A1 is embedded within reciprocal endocrine regulation. Intestinal CYP24A1 can control local signalling without producing an equivalent change in circulating vitamin D metabolites.
Important uncertainties remain. The contribution of alternative catabolic pathways varies with biological context. Calcitonin effects differ between models. Direct calcium and phosphate sensing mechanisms are incompletely mapped. FGF23 responses vary with experimental setting. The Fuchs study remains animal evidence rather than proof of a human treatment effect.
Primary sources and publication details
Jones, Prosser and Kaufmann
Jones G, Prosser DE, Kaufmann M.
Cytochrome P450-mediated metabolism of vitamin D.
Journal of Lipid Research. 2014;55(1):13 to 31.
PMID: 23564710
PMCID: PMC3927478
DOI: 10.1194/jlr.R031534
View the verified primary source
Young, Beggs, Grimbly and Alexander
Young K, Beggs MR, Grimbly C, Alexander RT.
Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule.
Experimental Biology and Medicine. 2022;247(13):1103 to 1111.
PMID: 35482362
PMCID: PMC9335508
DOI: 10.1177/15353702221091982
View the verified primary source
Fuchs and colleagues
Fuchs MAA, Grabner A, Shi M, et al.
Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice.
Journal of Clinical Investigation. 2025;135(4):e179882.
PMID: 39688907
PMCID: PMC11827884
DOI: 10.1172/JCI179882
View the verified primary source
Related reading
Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
Vitamin D regulates mineral homeostasis.
Original paper ↗Read more →CYP24A1 Exacerbated Activity during Diabetes Contributes to Kidney Tubular Apoptosis via Caspase-3 Increased Expression and Activation
Decreases in circulating 25,hydroxyl-vitamin D3 (25 OH D3) and 1,25,dihydroxyl-vitamin D3 (1,25 (OH)2 D3) have been extensively documented in patients with type 2 diabetes.
Original paper ↗Read more →The age-related changes of dietary phosphate responsiveness in plasma 1,25-dihydroxyvitamin D levels and renal Cyp27b1 and Cyp24a1 gene expression is associated with renal α-Klotho gene expression in mice
We found that 1,25-dihydroxyvitamin D levels in plasma were significantly lower in the high phosphate group than the low phosphate group for 1 and 2 month-old mice, but not 13 month-old mice.
Original paper ↗Read more →Renal and Intestinal CYP24A1 Regulation: Study Summary
Study summary of Fuchs and colleagues examining how renal and intestinal CYP24A1 have distinct roles in systemic and local vitamin D clearance.
Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers
In patients with recurrent calcium oxalate containing stones, we investigated both, the consequence of a low-sodium diet on urinary volume and calcium excretion, and the influence of a low-sodium low-calcium diet on urinary oxalate excretion.
Original paper ↗Read more →Dietary phosphorus source reprograms the kidney-intestine axis to dictate calcium-phosphorus efficiency and egg production in aging hens
The decline in egg production in aging hens poses a significant challenge to sustainable poultry production.
Original paper ↗Read more →FGF23 promotes renal calcium reabsorption through the TRPV5 channel
αKlotho is thought to activate the epithelial calcium channel Transient Receptor Potential Vanilloid-5 (TRPV5) in distal renal tubules through its putative glucuronidase/sialidase activity, thereby preventing renal calcium loss.
Original paper ↗Read more →Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study
We aimed to describe the effect of the calcium phosphate product (Ca*P) on FGF-23 concentrations in children and young adults without confounding cardiovascular disease.
Original paper ↗Read more →Impact of Calcium-Magnesium Ratio in Purified Water Remineralization on Calcium Oxalate Crystal Formation and Renal Injury
Objectives: This study investigates the impact of different Ca:Mg in the remineralization of purified water on calcium oxalate crystallization and renal injury.
Original paper ↗Read more →Impact of microgravity on a three-dimensional microphysiologic culture of the human kidney proximal tubule epithelium: cell response to serum and vitamin D
We used this unique environment to evaluate the effects of microgravity on kidney proximal tubule epithelial cell (PTEC) response to serum exposure and vitamin D biotransformation capacity.
Original paper ↗Read more →Klotho in the kidney distal convolution regulates urinary Klotho excretion and kidney calcium reabsorption, but not phosphate homeostasis
Klotho acts as a coreceptor for the phosphaturic hormone fibroblast growth factor-23 (FGF-23) and exists in both a membrane-bound and a soluble form (sKlotho) found in blood and urine.
Original paper ↗Read more →Low Magnesium Concentration Enforces Bone Calcium Deposition Irrespective of 1,25-Dihydroxyvitamin D3 Concentration
Efficient coordination between Mg2+ and vitamin D maintains adequate Ca2+ levels during lactation.
Original paper ↗Read more →Modeling cellular responses to serum and vitamin D in microgravity using a human kidney microphysiological system
We used this unique environment to evaluate the effects of microgravity on kidney proximal tubule epithelial cell (PTEC) response to serum exposure and vitamin D biotransformation capacity.
Original paper ↗Read more →Persistent changes in calcium-regulating hormones and bone turnover markers in living kidney donors more than 20 years after donation
In our recent survey-based study, we found no increased risk of fractures of all types but observed significantly more vertebral fractures in LKDs compared with matched controls.
Original paper ↗Read more →Positive association between serum calcium-phosphorus ratio and kidney stone prevalence: Analysis of NHANES data (2007 to 2020)
This study utilized data from the 2007 to 2020 National Health and Nutrition Examination Survey (NHANES), including a total of 34,122 participants.
Original paper ↗Read more →Regulation of tight junction gene expression in the kidney of calbindin-D9k and/or: D28k knockout mice after consumption of a calcium: or a calcium/vitamin D-deficient diet
Transcripts and proteins of tight junction related genes (occludin, ZO-1, and claudins) were examined in CaBP-9 k-and/or-28 k-deficient mice as well as the effect of dietary calcium and/or vitamin D supplementation.
Original paper ↗Read more →The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss: a case report
Demineralisation and bone density loss during immobilisation are known phenomena.
Original paper ↗Read more →The predictive value of 24-hour urinary calcium for kidney stone risk in primary hyperparathyroidism: insight from a retrospective study of parathyroid adenoma cases
Primary hyperparathyroidism (PHPT) is associated with an increased risk of kidney stones.
Original paper ↗Read more →Vitamin D Clearance and Degradation
Explains how vitamin D is inactivated and cleared through regulated enzymatic and organ-level processes, shaping duration, turnover, and functional availability rather than deficiency.
Read more →Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding
However, in silico docking experiments demonstrated that VD1-6 was predicted to have superior binding to CYP24A1, when compared to that of 1,25(OH)2D3.
Original paper ↗Read more →Original sources
View the verified primary source
View the verified primary source.
Publication details
View the verified primary source
View the verified primary source
View the verified primary source.
Publication details
View the verified primary source
Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
Vitamin D regulates mineral homeostasis.
Publication details
View the verified primary source